$Bob's and Jbem's Bitchin' Bios

[value1008]

RLYP-- yes, very strong here.... Just surpassed the intraday high the other day (17.47). Next minor resistance area would be in that band where the stock consolidated in first half of Oct-- the upper $17 to upper $19 area. 50dma lies above that, presently at 20.13. I bet the stock is running up toward the 50dma by end of week or early next week.

Analyst price targets, as you have posted, Kei, are far too high compared to where RLYP still is valued. Moreover, in comparison with ZSPH, RLYP has their treatment approved by FDA and will be first to the market-- there's no way that ZSPH should still have a valuation somewhere around 2.5 times higher than RLYP. Even if ZSPH gets approval for their drug, both companies look like they'll each grab a healthy chunk of the market in the USA. And Europe does not even seem to be factored into RLYP's s/price yet.